Sorafenib monotherapy in patients with inoperable/recurrent germ cell tumors (GCT) refractory to chemotherapy: Phase II study.
Iwona Anna Skoneczna
Honoraria - Bayer
Research Funding - Bayer
Urszula Natorska
No relevant relationships to disclose
Malgorzata Tacikowska
No relevant relationships to disclose
Ewa Kraszewska
No relevant relationships to disclose
Beata Kotowicz
No relevant relationships to disclose
Malgorzata Fuksiewicz
No relevant relationships to disclose
Wojciech W Rogowski
No relevant relationships to disclose
Irena Federowicz
No relevant relationships to disclose
Grazyna Poniatowska
No relevant relationships to disclose
Agnieszka Chaladaj-Kujawska
No relevant relationships to disclose
Wojciech Michalski
No relevant relationships to disclose